Miguel Escobar/WFH
Aug 2, 2025, 16:50
Chromogenic Assays Underused in Females with Hemophilia A
The World Federation of Hemophilia (WFH) shared a post on X:
”A global survey of hemophilia providers shows that chromogenic assays versus one stage assays are ordered far less often in females than males—pointing to gaps in access, awareness, and clinical approach.
Read the full article.”
Article: Chromogenic vs one-stage assay to diagnose women and girls with hemophilia A—mapping global approaches and assessing challenges: communication from the SSCs of the ISTH
Authors: Lakshmi Srivaths, Joanna Larson, Karin Fijnvandraat, Jesus Ardila, Miguel Escobar
Find similar posts on Hemostasis Today.
-
Feb 26, 2026, 15:58Daniel Victor Ortigoza։ Lipoprotein(a) Levels Predict Long-Term Cardiovascular Risk in Women
-
Feb 26, 2026, 15:51Augustina Isioma Ikusemoro: The Real Miracle in Trauma Care Happens Behind the Scenes
-
Feb 26, 2026, 15:42Jim Hoffman։ Targeting NETosis to Improve Perfusion and Reduce Thrombosis in AMI
-
Feb 26, 2026, 15:40Elvira Grandone: ISTH Launches An International Survey to Capture Real-World Practice of Pregnancy Anemia
-
Feb 26, 2026, 15:39Ashok Yadav: Placental Glycogen as a Vital Energy Reserve for Fetal and Placental Health
-
Feb 26, 2026, 15:37Nayab Ahmed: Main Reasons for Washing Platelet-Rich Plasma
-
Feb 26, 2026, 15:36Robert Negrin Shares His Outlook for the Year Ahead as ASH President
-
Feb 26, 2026, 15:24Nancy Shapiro: Excited to See This Publication on Current Landscape of Anticoagulation Stewardship Released
-
Feb 26, 2026, 15:15Ahmed Nasreldein: Stay Current on Key Updates in Ischemic and Hemorrhagic Stroke